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The  assertion  that  Brazilian  scientiﬁc  production  is  among
the  fastest  growing  in  the  world  can  be  supported  by  ana-
lyzing  the  data  published  in  several  platforms.  From  2001
to  2011,  in  the  worldwide  scenario,  Brazil  moved  from  13th
to  7th  place  in  the  number  of  published  articles.  This  fact
should  be  something  to  be  proud  of;  nonetheless,  when  we
analyze  the  quality  of  these  articles  and  their  contributions
with  respect  to  innovation  and  technology,  the  opposite  of
pride  is  evident.
Let  us  ﬁrst  consider  the  quality.  According  to  a  recent
article  published  in  Nature,  Brazilian  publications  occupy
only  1%  of  those  selected  by  more  renowned  journals.  How
can  this  discrepancy  be  explained?  The  number  of  Brazilian
journals  that  became  integrated  into  databases  during  that
time  period  increased  from  62  to  270.  In  other  words,  the
increase  was  not  due  to  the  higher  acceptance  of  our  arti-
cles  by  journals  with  higher  impact,  i.e.,  we  gained  rank  by
taking  shortcuts!
What  about  innovation?  Innovation  from  scientiﬁc  studies
has  a  single  measurable  criterion:  the  number  of  resul-
ting  patents.  Brazil  is  one  of  the  countries  with  the  lowest
number  of  registered  patents,  and  according  to  the  Patent
Cooperation  Treaty  (PCT),  2011,  its  participation  in  the
global  market  is  only  0.2%.  Considering  this  0.2%,  should  we
be  proud  of  our  Brazilian  institutions?  Another  surprise!  In
the  more  advanced  areas  of  technology,  the  foreign  institu-
tion  patents  accounted  for  90%  of  the  total!  This  is  alarming;
the  reason  for  this  discrepancy  is  the  fact  that  most  of  our
researchers  belong  to  public  universities.
In  a  survey  conducted  in  2009  (UFPE),  of  the  existing
85,000  PhDs,  only  2%  were  employed  in  companies,  and
in  2010  alone,  12,000  new  doctors  obtained  their  degrees,
which  is  equal  to  the  number  from  countries  that  are  leaders Please cite this article as: Pontes P. Brazilian scientiﬁc pro-
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f  innovation.  The  conclusion  that  can  be  drawn  from  this
aradox  is  that  at  Brazilian  universities,  researchers  are
ressed  to  publish  increasingly  more,  regardless  of  quality!
n  the  present  situation,  it  is  more  rewarding  for  professors
o  publish  more,  and  obtain  greater  resources  from  fund-
ng  agencies  than  to  produce  innovative  ideas  that  could
orward  the  country’s  progress.
It  is  essential  that  public  universities,  funded  by  the  peo-
le,  break  down  ideological  barriers  and  turn  to  the  private
ector,  within  a  paradigm  now  universally  known  as  ‘‘open
nnovation’’,  where  the  partnership  between  universities
nd  private  companies  establishes  common  and  secure  goals
nd  strategies,  without  the  political  wrangling  that  leads  to
orruption.  In  that  way,  the  beneﬁts  would  be  returned  to
ociety:  universities  contribute  with  researchers  and  compa-
ies  with  resources,  logistics,  and  distribution  of  products,
ith  an  ethical  economic  return  for  all  and  with  massive
ocial  beneﬁts.
Then,  here  in  Brazil,  the  industries  that  sell  only  imported
echnologies  could  produce  more  of  them  and  the  univer-
ities  would  no  longer  produce  only  researchers  for  their
wn  interests.  It  is  necessary  to  unite  the  partners.  In  the
eld  of  medicine,  the  means  for  better  public  health  have
een  introduced,  but  nobody  has  thought  of  the  products,
ost  of  them  imported.  According  to  ofﬁcial  ﬁgures,  in  2012
e  exported  R$  1.5  billion  of  medications  and  imported  R$
.4  billion!  Government  policy  must  also  attempt  to  match
esearch  to  the  market,  but  we  are  far  from  it.  The  legal  and
dministrative  system  of  our  universities  does  not  allow  this
ractice;  we  must  give  Brazilian  public  universities  the  right
o  establish  free  associations  with  enterprises  or  private
nstitutions  for  innovation  and  technology,  with  the  auton-
my  to  raise,  direct,  and  manage  both  human  and  ﬁnancial
esources.With  this,  a  greater  number  of  inventions  would  be  pro-
uced  in  Brazil  and  would  obtain  patents.  Most  of  the
esearchers  are  found  in  the  universities  and  belong  to  the
ystem  of  grants,  in  which  publication  is  the  most  relevant
rgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights
3a
l
a
f
I
s
l
s
a
o
t
d
t
p
l
t
t
p
a
a
s
b
b
d
C
T
Department  of  Otorhinolaryngology  and  Head  and  Neck44  
spect;  when  a  paper  is  published,  the  aspect  of  novelty  is
ost,  an  essential  condition  for  the  patent  to  be  obtained,
nd  the  innovation  becomes  public  domain.  The  country  that
unded  the  research  does  not  obtain  the  deserved  return!
n  the  same  sense,  at  our  universities  interest  is  lost  in
cientiﬁc  production,  because  public  universities  are  pub-
ic  companies  and  their  employees  have  the  right  of  job
ecurity,  whether  they  have  teaching  or  administrative  jobs,
nd  their  career  advancement  is  attained  according  to  time
f  employment.  Thus,  the  decisions  of  the  board  of  direc-
ors,  dominated  by  representatives  of  class-based  interests,
eplete  the  resources  that  should  be  directed  to  research,
eaching,  and  continuing  education,  which  should  be  the
urpose  of  universities.What  is  the  role  of  the  Brazilian  Journal  of  Otorhino-
aryngology  in  this  scenario?  Medicine  is  the  scientiﬁc  area
hat  has  shown  the  greatest  growth  in  Brazil  and  within
his  area,  clinical  research,  which  is  invaluable  to  medicalEDITORIAL
ractice  and  whose  main  beneﬁciary  is  society.  Thus,
lthough  our  journal  has  been  fulﬁlling  its  mission  on  an
dmirable,  ascending  path,  following  rigorous  scientiﬁc
election,  the  time  has  come  to  include  potential  or  actual
eneﬁt  for  innovation  in  our  selection  criteria,  which  will
ring  contributions  to  Brazil  towards  its  destination  as  a
eveloped  and  independent  nation.
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